

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 4.87065528 |
| 2 | lactate metabolic process (GO:0006089) | 4.66160639 |
| 3 | respiratory chain complex IV assembly (GO:0008535) | 4.29611135 |
| 4 | regulation of hexokinase activity (GO:1903299) | 4.19424037 |
| 5 | regulation of glucokinase activity (GO:0033131) | 4.19424037 |
| 6 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.00884631 |
| 7 | proteasome assembly (GO:0043248) | 3.99803433 |
| 8 | protein complex biogenesis (GO:0070271) | 3.98714413 |
| 9 | cytochrome complex assembly (GO:0017004) | 3.78427254 |
| 10 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.73103572 |
| 11 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.53729013 |
| 12 | response to pheromone (GO:0019236) | 3.43500123 |
| 13 | ATP synthesis coupled proton transport (GO:0015986) | 3.39596997 |
| 14 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.39596997 |
| 15 | fucose catabolic process (GO:0019317) | 3.38508665 |
| 16 | L-fucose metabolic process (GO:0042354) | 3.38508665 |
| 17 | L-fucose catabolic process (GO:0042355) | 3.38508665 |
| 18 | cellular ketone body metabolic process (GO:0046950) | 3.37786315 |
| 19 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.37684970 |
| 20 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.33361732 |
| 21 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.33309330 |
| 22 | NADH dehydrogenase complex assembly (GO:0010257) | 3.33309330 |
| 23 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.33309330 |
| 24 | cullin deneddylation (GO:0010388) | 3.30446513 |
| 25 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.26976095 |
| 26 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.24552971 |
| 27 | ketone body metabolic process (GO:1902224) | 3.22762680 |
| 28 | nucleoside transmembrane transport (GO:1901642) | 3.21610897 |
| 29 | mannosylation (GO:0097502) | 3.17313038 |
| 30 | rRNA modification (GO:0000154) | 3.14772894 |
| 31 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.11408686 |
| 32 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.10876995 |
| 33 | peptidyl-histidine modification (GO:0018202) | 3.10725064 |
| 34 | positive regulation of glycolytic process (GO:0045821) | 3.06789058 |
| 35 | keratinocyte development (GO:0003334) | 3.06588355 |
| 36 | protein deneddylation (GO:0000338) | 2.98948568 |
| 37 | rRNA methylation (GO:0031167) | 2.98155475 |
| 38 | positive regulation of respiratory burst (GO:0060267) | 2.97427207 |
| 39 | platelet dense granule organization (GO:0060155) | 2.97041441 |
| 40 | electron transport chain (GO:0022900) | 2.95286192 |
| 41 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.95211425 |
| 42 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.95211425 |
| 43 | inositol phosphate dephosphorylation (GO:0046855) | 2.94899495 |
| 44 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.94899495 |
| 45 | respiratory electron transport chain (GO:0022904) | 2.92902339 |
| 46 | pseudouridine synthesis (GO:0001522) | 2.92879559 |
| 47 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.92735556 |
| 48 | negative regulation of acute inflammatory response (GO:0002674) | 2.91606006 |
| 49 | purine nucleobase biosynthetic process (GO:0009113) | 2.88208559 |
| 50 | inositol phosphate catabolic process (GO:0071545) | 2.88001957 |
| 51 | nucleobase biosynthetic process (GO:0046112) | 2.87914755 |
| 52 | protein-cofactor linkage (GO:0018065) | 2.85626492 |
| 53 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.84064905 |
| 54 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.82939643 |
| 55 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.81246777 |
| 56 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.81246777 |
| 57 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.81246777 |
| 58 | cytidine deamination (GO:0009972) | 2.80586919 |
| 59 | cytidine metabolic process (GO:0046087) | 2.80586919 |
| 60 | cytidine catabolic process (GO:0006216) | 2.80586919 |
| 61 | ubiquinone biosynthetic process (GO:0006744) | 2.79131036 |
| 62 | adenosine metabolic process (GO:0046085) | 2.78778216 |
| 63 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.78123339 |
| 64 | negative regulation of ligase activity (GO:0051352) | 2.78123339 |
| 65 | viral mRNA export from host cell nucleus (GO:0046784) | 2.76887787 |
| 66 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.76403339 |
| 67 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.75977913 |
| 68 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.73668892 |
| 69 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.73668892 |
| 70 | signal peptide processing (GO:0006465) | 2.70778484 |
| 71 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.70576734 |
| 72 | negative regulation of telomere maintenance (GO:0032205) | 2.70110191 |
| 73 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.69720623 |
| 74 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.69295891 |
| 75 | purine-containing compound salvage (GO:0043101) | 2.68493579 |
| 76 | phasic smooth muscle contraction (GO:0014821) | 2.68269431 |
| 77 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.68099825 |
| 78 | ubiquinone metabolic process (GO:0006743) | 2.66992679 |
| 79 | AMP metabolic process (GO:0046033) | 2.66752122 |
| 80 | positive regulation of prostaglandin secretion (GO:0032308) | 2.66206229 |
| 81 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.65713512 |
| 82 | intracellular protein transmembrane import (GO:0044743) | 2.65216731 |
| 83 | inner mitochondrial membrane organization (GO:0007007) | 2.63956763 |
| 84 | positive regulation of ligase activity (GO:0051351) | 2.62853929 |
| 85 | nucleoside diphosphate catabolic process (GO:0009134) | 2.62600057 |
| 86 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.61913111 |
| 87 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.61913111 |
| 88 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.60326741 |
| 89 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.59709772 |
| 90 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.58579199 |
| 91 | polyol catabolic process (GO:0046174) | 2.57387194 |
| 92 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.56050084 |
| 93 | aldehyde catabolic process (GO:0046185) | 2.55190030 |
| 94 | branched-chain amino acid catabolic process (GO:0009083) | 2.53305974 |
| 95 | tRNA processing (GO:0008033) | 2.53109543 |
| 96 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.52976154 |
| 97 | endocrine pancreas development (GO:0031018) | 2.51900405 |
| 98 | tRNA metabolic process (GO:0006399) | 2.50916846 |
| 99 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.50873101 |
| 100 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.50873101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.46457097 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.34503747 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.72999755 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.71199592 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.28307372 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.22600549 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.20653311 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 3.00962529 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.90689225 |
| 10 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.85340261 |
| 11 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.58873496 |
| 12 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.48649018 |
| 13 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.30480461 |
| 14 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.21716313 |
| 15 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.03567718 |
| 16 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.98236889 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.94986736 |
| 18 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.92180296 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.89650197 |
| 20 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.89568838 |
| 21 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.88307634 |
| 22 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.83262249 |
| 23 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79128856 |
| 24 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.71795031 |
| 25 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.70351435 |
| 26 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.68544416 |
| 27 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.64104636 |
| 28 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.61378709 |
| 29 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.58134537 |
| 30 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57150289 |
| 31 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.56292629 |
| 32 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.52406418 |
| 33 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.51222980 |
| 34 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.50051245 |
| 35 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.47123406 |
| 36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.46285137 |
| 37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.40188658 |
| 38 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.39924417 |
| 39 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.37448993 |
| 40 | EWS_26573619_Chip-Seq_HEK293_Human | 1.36281718 |
| 41 | FUS_26573619_Chip-Seq_HEK293_Human | 1.35861265 |
| 42 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.35717012 |
| 43 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.33792367 |
| 44 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.33792367 |
| 45 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.33452623 |
| 46 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.33364802 |
| 47 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.33364802 |
| 48 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.33158683 |
| 49 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.31936325 |
| 50 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.31500825 |
| 51 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.31333770 |
| 52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28659685 |
| 53 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.27961042 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.27881459 |
| 55 | AR_20517297_ChIP-Seq_VCAP_Human | 1.27628589 |
| 56 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.24516848 |
| 57 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.23427302 |
| 58 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.19026313 |
| 59 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.17580536 |
| 60 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.16231402 |
| 61 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.16199695 |
| 62 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.15878622 |
| 63 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.15808507 |
| 64 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.14414524 |
| 65 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.13113326 |
| 66 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.10933006 |
| 67 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.06924613 |
| 68 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.06397431 |
| 69 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.06321823 |
| 70 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.03795373 |
| 71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03743663 |
| 72 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.03454932 |
| 73 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.02825523 |
| 74 | NCOR_22424771_ChIP-Seq_293T_Human | 1.02763922 |
| 75 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.02731273 |
| 76 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.01024450 |
| 77 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.00296507 |
| 78 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.00224368 |
| 79 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.99456474 |
| 80 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.99252644 |
| 81 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.98235764 |
| 82 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.98107413 |
| 83 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.98088458 |
| 84 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.97932260 |
| 85 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.97399112 |
| 86 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.97399112 |
| 87 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.97273173 |
| 88 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.97272890 |
| 89 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.96535162 |
| 90 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.96055338 |
| 91 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.95718803 |
| 92 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.95664514 |
| 93 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.94761020 |
| 94 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.94392817 |
| 95 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.94031343 |
| 96 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.93661332 |
| 97 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.93518344 |
| 98 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.93354031 |
| 99 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.93296612 |
| 100 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.90703177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 3.88764684 |
| 2 | MP0003195_calcinosis | 3.66394507 |
| 3 | MP0002277_abnormal_respiratory_mucosa | 3.65323157 |
| 4 | MP0002102_abnormal_ear_morphology | 3.17010263 |
| 5 | MP0002638_abnormal_pupillary_reflex | 2.93188917 |
| 6 | MP0005075_abnormal_melanosome_morpholog | 2.88357615 |
| 7 | MP0000372_irregular_coat_pigmentation | 2.62282045 |
| 8 | MP0008877_abnormal_DNA_methylation | 2.60040362 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 2.30981215 |
| 10 | MP0002163_abnormal_gland_morphology | 2.30061576 |
| 11 | MP0005645_abnormal_hypothalamus_physiol | 2.28080551 |
| 12 | MP0005379_endocrine/exocrine_gland_phen | 2.20282247 |
| 13 | MP0000569_abnormal_digit_pigmentation | 2.12122539 |
| 14 | MP0004043_abnormal_pH_regulation | 2.11042493 |
| 15 | MP0002938_white_spotting | 2.09139265 |
| 16 | MP0004147_increased_porphyrin_level | 1.96828834 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 1.92304431 |
| 18 | MP0003787_abnormal_imprinting | 1.85186368 |
| 19 | MP0003646_muscle_fatigue | 1.82745190 |
| 20 | MP0008872_abnormal_physiological_respon | 1.82437282 |
| 21 | MP0000647_abnormal_sebaceous_gland | 1.80879401 |
| 22 | MP0003283_abnormal_digestive_organ | 1.77537823 |
| 23 | MP0002822_catalepsy | 1.77129675 |
| 24 | MP0006072_abnormal_retinal_apoptosis | 1.73774680 |
| 25 | MP0002909_abnormal_adrenal_gland | 1.70716011 |
| 26 | MP0001764_abnormal_homeostasis | 1.69718904 |
| 27 | MP0005253_abnormal_eye_physiology | 1.65925330 |
| 28 | MP0005646_abnormal_pituitary_gland | 1.64434251 |
| 29 | MP0002693_abnormal_pancreas_physiology | 1.62199526 |
| 30 | MP0003011_delayed_dark_adaptation | 1.61157493 |
| 31 | MP0005551_abnormal_eye_electrophysiolog | 1.60689655 |
| 32 | MP0002254_reproductive_system_inflammat | 1.50581885 |
| 33 | MP0006036_abnormal_mitochondrial_physio | 1.46942969 |
| 34 | MP0003718_maternal_effect | 1.44779162 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.44421433 |
| 36 | MP0002095_abnormal_skin_pigmentation | 1.41422836 |
| 37 | MP0001986_abnormal_taste_sensitivity | 1.39454160 |
| 38 | MP0001984_abnormal_olfaction | 1.34214356 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 1.30842887 |
| 40 | MP0001944_abnormal_pancreas_morphology | 1.30219073 |
| 41 | MP0002234_abnormal_pharynx_morphology | 1.28832681 |
| 42 | MP0003786_premature_aging | 1.19514538 |
| 43 | MP0002876_abnormal_thyroid_physiology | 1.19088320 |
| 44 | MP0005332_abnormal_amino_acid | 1.18527452 |
| 45 | MP0003693_abnormal_embryo_hatching | 1.17193299 |
| 46 | MP0009046_muscle_twitch | 1.17059814 |
| 47 | MP0001873_stomach_inflammation | 1.16895762 |
| 48 | MP0008058_abnormal_DNA_repair | 1.15702514 |
| 49 | MP0005410_abnormal_fertilization | 1.15496512 |
| 50 | MP0004142_abnormal_muscle_tone | 1.14673980 |
| 51 | MP0002751_abnormal_autonomic_nervous | 1.12392078 |
| 52 | MP0003186_abnormal_redox_activity | 1.11788963 |
| 53 | MP0005671_abnormal_response_to | 1.10727484 |
| 54 | MP0005360_urolithiasis | 1.08909430 |
| 55 | MP0001905_abnormal_dopamine_level | 1.08288538 |
| 56 | MP0003122_maternal_imprinting | 1.06841739 |
| 57 | MP0006292_abnormal_olfactory_placode | 1.06837071 |
| 58 | MP0009785_altered_susceptibility_to | 1.06034537 |
| 59 | MP0005389_reproductive_system_phenotype | 1.06020024 |
| 60 | MP0002160_abnormal_reproductive_system | 1.04799530 |
| 61 | MP0006035_abnormal_mitochondrial_morpho | 1.03895218 |
| 62 | MP0004885_abnormal_endolymph | 1.02824479 |
| 63 | MP0001501_abnormal_sleep_pattern | 1.01593192 |
| 64 | MP0004145_abnormal_muscle_electrophysio | 0.99544281 |
| 65 | MP0001661_extended_life_span | 0.99521210 |
| 66 | MP0005408_hypopigmentation | 0.99087025 |
| 67 | MP0008775_abnormal_heart_ventricle | 0.93376118 |
| 68 | MP0002557_abnormal_social/conspecific_i | 0.89557109 |
| 69 | MP0009643_abnormal_urine_homeostasis | 0.88707013 |
| 70 | MP0001835_abnormal_antigen_presentation | 0.87782290 |
| 71 | MP0001756_abnormal_urination | 0.87026267 |
| 72 | MP0004133_heterotaxia | 0.86190491 |
| 73 | MP0002148_abnormal_hypersensitivity_rea | 0.85410521 |
| 74 | MP0009333_abnormal_splenocyte_physiolog | 0.85127350 |
| 75 | MP0009745_abnormal_behavioral_response | 0.84769226 |
| 76 | MP0010094_abnormal_chromosome_stability | 0.84655959 |
| 77 | MP0002006_tumorigenesis | 0.84527357 |
| 78 | MP0003878_abnormal_ear_physiology | 0.82548118 |
| 79 | MP0005377_hearing/vestibular/ear_phenot | 0.82548118 |
| 80 | MP0002229_neurodegeneration | 0.82360083 |
| 81 | MP0001968_abnormal_touch/_nociception | 0.78955783 |
| 82 | MP0010329_abnormal_lipoprotein_level | 0.77804381 |
| 83 | MP0006082_CNS_inflammation | 0.77636577 |
| 84 | MP0002078_abnormal_glucose_homeostasis | 0.77473568 |
| 85 | MP0000427_abnormal_hair_cycle | 0.76569280 |
| 86 | MP0005220_abnormal_exocrine_pancreas | 0.75559501 |
| 87 | MP0001765_abnormal_ion_homeostasis | 0.73973662 |
| 88 | MP0005084_abnormal_gallbladder_morpholo | 0.73243633 |
| 89 | MP0001929_abnormal_gametogenesis | 0.73106083 |
| 90 | MP0002272_abnormal_nervous_system | 0.72056534 |
| 91 | MP0001790_abnormal_immune_system | 0.70915153 |
| 92 | MP0005387_immune_system_phenotype | 0.70915153 |
| 93 | MP0006276_abnormal_autonomic_nervous | 0.70865772 |
| 94 | MP0010386_abnormal_urinary_bladder | 0.68716803 |
| 95 | MP0003866_abnormal_defecation | 0.68642249 |
| 96 | MP0003943_abnormal_hepatobiliary_system | 0.68099515 |
| 97 | MP0001346_abnormal_lacrimal_gland | 0.66924898 |
| 98 | MP0001502_abnormal_circadian_rhythm | 0.66721757 |
| 99 | MP0008995_early_reproductive_senescence | 0.65221430 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.63397762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 3.78382410 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 3.69574250 |
| 3 | Acute encephalopathy (HP:0006846) | 3.58467156 |
| 4 | Hepatic necrosis (HP:0002605) | 3.52721158 |
| 5 | Progressive macrocephaly (HP:0004481) | 3.46296621 |
| 6 | Mitochondrial inheritance (HP:0001427) | 3.40490644 |
| 7 | Ketoacidosis (HP:0001993) | 3.36887227 |
| 8 | Hypothermia (HP:0002045) | 3.36843436 |
| 9 | Increased CSF lactate (HP:0002490) | 3.33549508 |
| 10 | Pancreatic cysts (HP:0001737) | 3.29636614 |
| 11 | Molar tooth sign on MRI (HP:0002419) | 3.24931904 |
| 12 | Abnormality of midbrain morphology (HP:0002418) | 3.24931904 |
| 13 | Hypomagnesemia (HP:0002917) | 3.24114526 |
| 14 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.19776692 |
| 15 | Hypoglycemic seizures (HP:0002173) | 3.10319541 |
| 16 | Increased hepatocellular lipid droplets (HP:0006565) | 3.06641255 |
| 17 | Anhidrosis (HP:0000970) | 3.01549598 |
| 18 | Abnormality of the pons (HP:0007361) | 2.99408588 |
| 19 | Hepatocellular necrosis (HP:0001404) | 2.97299890 |
| 20 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.89829047 |
| 21 | Renal cortical cysts (HP:0000803) | 2.88402098 |
| 22 | Lipid accumulation in hepatocytes (HP:0006561) | 2.87082595 |
| 23 | Pancreatic fibrosis (HP:0100732) | 2.81520197 |
| 24 | Hypoplasia of the pons (HP:0012110) | 2.81284967 |
| 25 | Abnormality of the renal cortex (HP:0011035) | 2.75265697 |
| 26 | Congenital stationary night blindness (HP:0007642) | 2.74979425 |
| 27 | Tongue fasciculations (HP:0001308) | 2.68493804 |
| 28 | True hermaphroditism (HP:0010459) | 2.64796962 |
| 29 | Abnormality of magnesium homeostasis (HP:0004921) | 2.63605586 |
| 30 | Attenuation of retinal blood vessels (HP:0007843) | 2.57662749 |
| 31 | Methylmalonic aciduria (HP:0012120) | 2.52926633 |
| 32 | Nephronophthisis (HP:0000090) | 2.50342084 |
| 33 | Methylmalonic acidemia (HP:0002912) | 2.49902724 |
| 34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.48700035 |
| 35 | Abnormality of methionine metabolism (HP:0010901) | 2.48393537 |
| 36 | Cerebral edema (HP:0002181) | 2.46233779 |
| 37 | Ketosis (HP:0001946) | 2.45462797 |
| 38 | Increased serum lactate (HP:0002151) | 2.40825106 |
| 39 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.38757369 |
| 40 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.38757369 |
| 41 | Symptomatic seizures (HP:0011145) | 2.34926977 |
| 42 | Renal Fanconi syndrome (HP:0001994) | 2.32649916 |
| 43 | Optic disc pallor (HP:0000543) | 2.32104552 |
| 44 | Generalized aminoaciduria (HP:0002909) | 2.31998426 |
| 45 | Large for gestational age (HP:0001520) | 2.30798382 |
| 46 | 3-Methylglutaconic aciduria (HP:0003535) | 2.30365662 |
| 47 | Hyperglycemia (HP:0003074) | 2.30043122 |
| 48 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.29565676 |
| 49 | Lactic acidosis (HP:0003128) | 2.26574701 |
| 50 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.20221777 |
| 51 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.20221777 |
| 52 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.18402107 |
| 53 | Respiratory failure (HP:0002878) | 2.17530775 |
| 54 | Stomatitis (HP:0010280) | 2.16824183 |
| 55 | Lethargy (HP:0001254) | 2.16244856 |
| 56 | Constricted visual fields (HP:0001133) | 2.13354641 |
| 57 | Type I transferrin isoform profile (HP:0003642) | 2.13271394 |
| 58 | Muscle fibrillation (HP:0010546) | 2.11638136 |
| 59 | Neoplasm of the adrenal gland (HP:0100631) | 2.06435838 |
| 60 | Neoplasm of the adrenal cortex (HP:0100641) | 2.04932020 |
| 61 | Medial flaring of the eyebrow (HP:0010747) | 2.03619467 |
| 62 | Abnormality of urine glucose concentration (HP:0011016) | 2.01479802 |
| 63 | Glycosuria (HP:0003076) | 2.01479802 |
| 64 | Abolished electroretinogram (ERG) (HP:0000550) | 2.01179477 |
| 65 | Dicarboxylic aciduria (HP:0003215) | 2.01153370 |
| 66 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.01153370 |
| 67 | Tetany (HP:0001281) | 1.98986129 |
| 68 | Cerebellar dysplasia (HP:0007033) | 1.97704654 |
| 69 | Abnormality of the renal medulla (HP:0100957) | 1.97151152 |
| 70 | Unilateral renal agenesis (HP:0000122) | 1.96201967 |
| 71 | Furrowed tongue (HP:0000221) | 1.94782056 |
| 72 | Tubular atrophy (HP:0000092) | 1.94471360 |
| 73 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.92793329 |
| 74 | Thyroiditis (HP:0100646) | 1.92322570 |
| 75 | Polydipsia (HP:0001959) | 1.92064278 |
| 76 | Abnormal drinking behavior (HP:0030082) | 1.92064278 |
| 77 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.90336840 |
| 78 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.90336840 |
| 79 | Abnormal protein glycosylation (HP:0012346) | 1.90336840 |
| 80 | Abnormal glycosylation (HP:0012345) | 1.90336840 |
| 81 | Microvesicular hepatic steatosis (HP:0001414) | 1.90207398 |
| 82 | Increased intramyocellular lipid droplets (HP:0012240) | 1.89665374 |
| 83 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.88469885 |
| 84 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.88372465 |
| 85 | Abnormality of the labia minora (HP:0012880) | 1.87298740 |
| 86 | Type II lissencephaly (HP:0007260) | 1.86555512 |
| 87 | Parakeratosis (HP:0001036) | 1.85653694 |
| 88 | Decreased central vision (HP:0007663) | 1.84440626 |
| 89 | Chronic hepatic failure (HP:0100626) | 1.84100431 |
| 90 | Acute hepatic failure (HP:0006554) | 1.82520665 |
| 91 | Cystic liver disease (HP:0006706) | 1.80507648 |
| 92 | IgG deficiency (HP:0004315) | 1.79724467 |
| 93 | Tachypnea (HP:0002789) | 1.78045507 |
| 94 | Exercise intolerance (HP:0003546) | 1.77205015 |
| 95 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.77189798 |
| 96 | Intestinal atresia (HP:0011100) | 1.76524415 |
| 97 | Severe muscular hypotonia (HP:0006829) | 1.75824124 |
| 98 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.74187918 |
| 99 | Type I diabetes mellitus (HP:0100651) | 1.73500316 |
| 100 | Abnormality of vitamin B metabolism (HP:0004340) | 1.73477549 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.89284604 |
| 2 | MST4 | 3.55853435 |
| 3 | ZAK | 3.42491634 |
| 4 | EIF2AK3 | 2.95352318 |
| 5 | MAP4K2 | 2.89738100 |
| 6 | NUAK1 | 2.50471610 |
| 7 | PASK | 2.42071537 |
| 8 | TSSK6 | 2.35201386 |
| 9 | ADRBK2 | 2.24489937 |
| 10 | GRK1 | 2.19109856 |
| 11 | VRK2 | 2.17001189 |
| 12 | TLK1 | 1.93884039 |
| 13 | PLK3 | 1.85749030 |
| 14 | BCKDK | 1.77221741 |
| 15 | TXK | 1.77127177 |
| 16 | BMPR1B | 1.69879958 |
| 17 | WNK3 | 1.60098087 |
| 18 | INSRR | 1.60022875 |
| 19 | TAOK3 | 1.51197300 |
| 20 | FGFR2 | 1.43321190 |
| 21 | VRK1 | 1.43040893 |
| 22 | MAP3K12 | 1.42590953 |
| 23 | MUSK | 1.39333395 |
| 24 | BUB1 | 1.37195141 |
| 25 | MKNK1 | 1.31149276 |
| 26 | TIE1 | 1.28492502 |
| 27 | CSNK1G3 | 1.24548139 |
| 28 | CSNK1G1 | 1.18135248 |
| 29 | PHKG2 | 1.17736435 |
| 30 | PHKG1 | 1.17736435 |
| 31 | NME1 | 1.17503429 |
| 32 | IKBKB | 1.14488423 |
| 33 | TRIM28 | 1.13159121 |
| 34 | MKNK2 | 1.12421547 |
| 35 | MAP2K6 | 1.10746714 |
| 36 | OXSR1 | 1.08537199 |
| 37 | SRPK1 | 1.08474811 |
| 38 | NEK1 | 1.05605633 |
| 39 | MAP3K13 | 1.05468954 |
| 40 | WNK4 | 1.05008621 |
| 41 | DAPK2 | 1.03997207 |
| 42 | CSNK1G2 | 1.01835598 |
| 43 | EIF2AK1 | 1.00657071 |
| 44 | PLK2 | 0.94289545 |
| 45 | ITK | 0.90314057 |
| 46 | MAPKAPK3 | 0.89556809 |
| 47 | ACVR1B | 0.87164820 |
| 48 | MAP3K14 | 0.83552956 |
| 49 | CSNK1A1L | 0.82865812 |
| 50 | BCR | 0.81587715 |
| 51 | TESK2 | 0.78429715 |
| 52 | PLK1 | 0.78048092 |
| 53 | LIMK1 | 0.75035498 |
| 54 | RPS6KA5 | 0.75012924 |
| 55 | FER | 0.74493260 |
| 56 | TAF1 | 0.73319515 |
| 57 | DYRK2 | 0.73023358 |
| 58 | DAPK1 | 0.72710241 |
| 59 | CDK19 | 0.69842865 |
| 60 | CHUK | 0.67370398 |
| 61 | PRKCE | 0.66919863 |
| 62 | EIF2AK2 | 0.64382900 |
| 63 | MAPKAPK5 | 0.64218671 |
| 64 | NEK9 | 0.63313290 |
| 65 | PINK1 | 0.62422003 |
| 66 | PRKCQ | 0.61268436 |
| 67 | IKBKE | 0.60782023 |
| 68 | ERBB3 | 0.60466376 |
| 69 | ATR | 0.59899202 |
| 70 | NLK | 0.59800977 |
| 71 | PRKCG | 0.59637901 |
| 72 | FGFR3 | 0.59007802 |
| 73 | SIK3 | 0.58832274 |
| 74 | PBK | 0.58582077 |
| 75 | KIT | 0.57772233 |
| 76 | PLK4 | 0.57118452 |
| 77 | NME2 | 0.56975310 |
| 78 | STK16 | 0.56629498 |
| 79 | TEC | 0.55829016 |
| 80 | IRAK1 | 0.54134649 |
| 81 | BRSK2 | 0.53695470 |
| 82 | PTK2B | 0.52484041 |
| 83 | FLT3 | 0.48501187 |
| 84 | PRKAA2 | 0.48497166 |
| 85 | MAP2K7 | 0.46765099 |
| 86 | ADRBK1 | 0.44509508 |
| 87 | HIPK2 | 0.42062356 |
| 88 | PAK3 | 0.40787991 |
| 89 | MAP3K4 | 0.40488294 |
| 90 | TGFBR1 | 0.39727096 |
| 91 | ATM | 0.39481825 |
| 92 | WEE1 | 0.39280862 |
| 93 | KDR | 0.37736202 |
| 94 | CSNK1A1 | 0.37316072 |
| 95 | CSNK2A1 | 0.37257268 |
| 96 | TNIK | 0.36501724 |
| 97 | CSNK2A2 | 0.34893815 |
| 98 | STK3 | 0.34841116 |
| 99 | TNK2 | 0.34095820 |
| 100 | PRKCA | 0.32187729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.07194782 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.97026880 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.33902510 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.76933941 |
| 5 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.44136316 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.36237651 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.11946614 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.03649804 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.97960646 |
| 10 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.97600814 |
| 11 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.92805587 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92716132 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.90652495 |
| 14 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.89145546 |
| 15 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.85016022 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.80417235 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 1.78398752 |
| 18 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60683816 |
| 19 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57136877 |
| 20 | Basal transcription factors_Homo sapiens_hsa03022 | 1.51701780 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.45919300 |
| 22 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.44063878 |
| 23 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.40126968 |
| 24 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.38674519 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 1.36158980 |
| 26 | RNA degradation_Homo sapiens_hsa03018 | 1.31791887 |
| 27 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31105682 |
| 28 | RNA transport_Homo sapiens_hsa03013 | 1.30943985 |
| 29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.30185134 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.29863129 |
| 31 | Huntingtons disease_Homo sapiens_hsa05016 | 1.28407313 |
| 32 | Mismatch repair_Homo sapiens_hsa03430 | 1.26477695 |
| 33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.22545771 |
| 34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.20986643 |
| 35 | Alzheimers disease_Homo sapiens_hsa05010 | 1.16385770 |
| 36 | Purine metabolism_Homo sapiens_hsa00230 | 1.15254446 |
| 37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13175607 |
| 38 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.11619074 |
| 39 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.10503550 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.08635098 |
| 41 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.05786098 |
| 42 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.03126560 |
| 43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.99190260 |
| 44 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.98660328 |
| 45 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97618583 |
| 46 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.96740310 |
| 47 | Allograft rejection_Homo sapiens_hsa05330 | 0.94941016 |
| 48 | Asthma_Homo sapiens_hsa05310 | 0.94880003 |
| 49 | DNA replication_Homo sapiens_hsa03030 | 0.93394598 |
| 50 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.92845428 |
| 51 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.92689397 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.91701333 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.89921180 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.89772715 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88109672 |
| 56 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86610211 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.83456656 |
| 58 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.82406577 |
| 59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.81857993 |
| 60 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.80705310 |
| 61 | Metabolic pathways_Homo sapiens_hsa01100 | 0.80131308 |
| 62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.76401458 |
| 63 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75815349 |
| 64 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.74983256 |
| 65 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.72392892 |
| 66 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.70588948 |
| 67 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.70313443 |
| 68 | Base excision repair_Homo sapiens_hsa03410 | 0.70150887 |
| 69 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.69304931 |
| 70 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.69036586 |
| 71 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.68171191 |
| 72 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.66472284 |
| 73 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.61686914 |
| 74 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.61416507 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.60144618 |
| 76 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.59512060 |
| 77 | Taste transduction_Homo sapiens_hsa04742 | 0.59231571 |
| 78 | Spliceosome_Homo sapiens_hsa03040 | 0.58796392 |
| 79 | Retinol metabolism_Homo sapiens_hsa00830 | 0.58060135 |
| 80 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.57856909 |
| 81 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.57630086 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57335126 |
| 83 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56432670 |
| 84 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.56004510 |
| 85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.54863051 |
| 86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52830832 |
| 87 | Insulin secretion_Homo sapiens_hsa04911 | 0.52487870 |
| 88 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51005508 |
| 89 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48465201 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | 0.47955131 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46349712 |
| 92 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.46292773 |
| 93 | Olfactory transduction_Homo sapiens_hsa04740 | 0.45841309 |
| 94 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44116582 |
| 95 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42587655 |
| 96 | Ribosome_Homo sapiens_hsa03010 | 0.42436840 |
| 97 | Carbon metabolism_Homo sapiens_hsa01200 | 0.38248694 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36699803 |
| 99 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.35322627 |
| 100 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.35279339 |

